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A murine model was utilized to test the influence of heavy metal 
protoporphyrins on burn conversion, heme oxygenase – 1 (HO-1) expression, and 
inflammation. Heavy metal protoporphyrins, such as cobalt protoporphyrin (Co PP) and 
tin protoporphyrin (Sn PP), were used to influence the heme oxygenase activity. The 
effects of these heavy metal protoporphyrins on burn wound conversion were examined 
using a burn comb model in rats. 
In addition to assessing the extent of conversion, HO-1 expression and 
parameters of inflammation were also examined in the area of injury (interspace region) 
subject to conversion.  These studies demonstrate proof in principal that pharmacologic 
 xi  
agents known to modify HO activity can also modulate burn wound conversion.  
Improved outcome correlated with HO-1 expression/activity and reduced inflammation.  
This suggests that one of the mechanisms utilized by HO-1 to improve burn wound 
outcome involves modulation of one or more components of the inflammatory response.  
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Introduction 
 
General Purpose 
 
 In the United States, approximately two million people each year are subject to 
burn injury. Of these, 80,000 require hospitalization, and 6,500 die as a direct or 
indirect result of their burn injuries. (Singh, Devgan et al., 2007) Burns and their 
recorded treatment date back to the 15th century B.C. In the Ebers papyrus, burn wounds 
were treated with “cattle dung and black mud” (Weeks & Xu, 2004). It was not until the 
twentieth century that significant progress in the treatment of burn wounds occurred.  
With the First World War, autologous surgical skin grafts came into use and beginning 
in the 1960s fluid resuscitation techniques greatly reduced mortality resulting from 
shock. (Weeks & Xu, 2004) 
One of the significant problems that are still encountered with burn wounds is 
conversion.  For reasons that are not entirely appreciated, burn wound severity is not 
always static and can progressively worsen following the initial injury.  This is 
clinically relevant because it not only confounds diagnosis but, burns that progress from 
partial-thickness to full-thickness injury are at a much greater risk for hypertrophic 
scarring  and contracture. Full-thickness burn wounds also put the individual at 
increased risk for sepsis and require surgical interventions. Although the mechanisms 
behind burn wound conversion are incompletely understood, there is a consensus that 
inflammation plays a major role. (Singh, Devgan et al., 2007) 
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The stress protein, heme oxygenase-1 (HO-1) generates products with anti-
inflammatory functions.  The expression and activity of HO-1 can be pharmacologically 
modulated by heavy metal protoporphyrins.  Therefore, the goals of this study were:    
1. test whether heavy metal protoporphyrins influence burn conversion 
2. test whether protoporphyrins influence HO – 1 expression  
3. test whether heavy metal protoporphyrins influence inflammation, using 
markers such as myeloperoxidase (MPO) and matrix metalloproteinase 
(MMP) expression 
 
Hypothesis 
 
 Experimental analysis will demonstrate that heavy metal protoporphyrins, tin 
protoporphyrin (Sn PP) and cobalt protoporphyrin (Co PP) will have an effect on the 
conversion of the burn injury. By testing the key elements in the Co PP and Sn PP 
treated inflamed tissue, will show that HO-1 expression is increased. Heavy metal 
protoporphyrins should modulate HO-1 expression. Inflammation and necrosis should 
correlate with an environment in which HO-1 is inhibited, and should inversely 
correlate with a pharmacologic regimen that increased HO-1 activity. There is a 
correlation between Co PP and Sn PP treatments that modulate HO-1 
expression/activity with inflammation and necrosis. Co PP and Sn PP should be 
observed to have a significant influence on the inflammation of the burned tissue and 
MMP expression.     
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Background 
 
When skin is heated, it is subject to damage as a result of the transfer of thermal 
energy.  Temperature and duration of exposure are the two most important determinants 
of the degree of injury.  Physics dictates that thermal damage is dependent upon the 
quantity of heat that is transferred and the extent to which it is dissipated.  The last two 
decades have seen significant advances in burn care.  The number of deaths annually in 
the United States is now less than a third of that seen in 1970.  Moreover, the size of 
burn associated with a 50 percent survival rate has increased from 30% of the total body 
surface area to well over 80% in otherwise healthy adults. (Warden & Heimbach, 1999)  
The skin is composed of layers, all of which can be affected by a burn depending on 
the severity. The three main layers are the epidermis, dermis, and hypodermis. The 
epidermis consists of different types of cells: keratinocytes, melanocytes, Merkels cells, 
and Langerhans cells. Blood vessels can not be found in the epidermis, but oxygen and 
nutrients reach the tissue by way of diffusion from the dermis. The main function of the 
epidermis is to act as a protective barrier. The epidermis is divided into five separate 
layers. Starting from the top, there is the stratum corneum, stratum lucidum, stratum 
granulosum, stratum spinosum, and the stratum basale, which borders the dermis. The 
stratum corneum is composed of dead cells or cells that are close to death. This sub-
layer of the epidermis acts as a protective surface due to the strength of the keratin 
protein in the dying cells. Although this layer has many dying cells, hydration is still 
possible. The stratum lucidum is only apparent in thick skin which helps to decrease  
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friction. The stratum granulosum contains keratinocytes which produce keratin proteins 
and lipids responsible for hydration of the epidermis. The stratum spinosum again 
contains keratinocytes which begin the production of keratin. Langerhans cells are also 
found in the stratum spinosum and are very important to the epidermis. These cells 
relay signals to the immune system and help to protect to body from foreign invaders or 
any other trauma to the skin. The last layer of the epidermis is the stratum basale and its 
main function is to form new cells that are forced upward as the stratum corneum 
sloughs off dying cells. The stratum basale contains melanocytes and Merkels cells. 
Melanocytes produce melanin pigment to help protect the skin from sun damage. 
Merkels cells do not have a determined function, but could potentially be related to the 
touch sense. (Brannon, 2007; Gary, 2008; Kenet & Lawyer, 1994)  
The dermis is made up of two layers: papillary and reticular layer. The upper level is 
the papillary dermis and the lower level is the reticular dermis. The whole dermis is 
formed from connective tissue. Specifically, the papillary layer is composed of thin 
collagen fibers and the reticular layer is made up of thick collagen fibers, which provide 
support. There are many more components involved in the dermis. Elastin runs 
throughout this layer, which provides elasticity to the skin.  The dermis also contains 
hair follicles and erector pili muscles, sweat glands, blood vessels, lymph vessels, and 
nerves.  Meissner’s and Pacini corpuscles in the dermis sense touch and pressure. 
Histiocytes are found in the dermis as well, and serve as important factors involved in 
the healing process and regeneration of the epidermis. Monocytes derived from the 
bone marrow become histiocytes when arriving in the dermis in response to trauma.  
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Overall, the dermis provides elasticity, support, and strength to the skin and begins 
the process of repair. (Gomez & Cancio, 2007) Therefore, the deeper a burn progresses 
into the skin, the more severe a burn (Singh, Devgan et al., 2007).  
The innermost layer of the skin is the hypodermis. The hypodermis contains much 
of the fat stored in the body, but also consists of connective tissue, large blood vessels, 
hair follicle roots, and nerve endings. The adipose cells in this layer act as a shock 
absorber and provide insulation for the body. (Hettiaratchy & Dziewulski  2004; 
Benson, Dickson et al., 2006) 
The extent of burn wound damage in the layers of the skin is commonly classified in 
terms of degrees.  First degree burns (or superficial burns) are the most minor and do 
the least amount of damage. These burns will make the skin turn pink or red and only 
affects the epidermis. An example would be a typical sun burn. Second degree burns (or 
partial-thickness burns) extend deeper into the skin and involve all or part of the dermis.  
Second degree burns can be sub-classified as superficial partial-thickness burns 
(involving the papillary dermis) or deep partial-thickness burns (involving the papillary 
and reticular dermis). Second degree burns result in blistering of the skin, can be painful 
depending on the quantity and depth of nerves affected, and result in damage to the 
epidermis and dermis.  Third degree burns involve the epidermis, dermis, and extend 
into the subcutaneous tissues.  Severe burns can involve muscle and bone. (Barton, 
Kokoska et al., 2006; Gomez & Cancio, 2007) See Figure 1.  
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Figure 1: Degree Levels of Burns 
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In addition, individual burn wounds are also defined in terms of evolving injury. 
Burn wound conversion is a process in which superficial burns develop into deeper burn 
wounds. Jackson was the first to determine that a burn can be observed as three separate 
zones: the zone of coagulation, the zone of stasis, and the zone of hyperemia. See 
Figure 2. The zone of coagulation refers to the area of injured tissue which has received 
irreversible damage. The tissue has been destroyed and the cells die extremely quickly. 
This area is void of any blood flow and damage is irreversible. Deep and peripheral to 
the zone of coagulation is the zone of stasis.  Due to direct thermal effects, the 
microvasculatures in this region dilate and its endothelial lining 'leaks' plasma and 
intravascular proteins.  With time, the circulation in this region ceases as the capillaries 
become packed with red blood cells and microthrombi, aggravating the inflammatory 
response. With appropriate treatment, the cellular damage in this region is potentially 
reversible. The outermost zone is the zone of hyperemia. Damage in this area is severe, 
but not permanent. The blood flow increases daily and healing should be apparent after 
about a week. (Gomez & Cancio, 2007; Singh, Devgan et al., 2007)  
“The depth of burn wounds is not entirely static, however, and multiple factors, each 
acting via a variety of pathophysiologic mechanisms, can promote the deepening of 
a burn wound. In a subacute time frame of 3–5 days, burns originally assessed to be 
superficial partial thickness have been observed to progress into deep partial-thickness 
or full-thickness burns. This process of progressive damage to initially unburned tissue 
surrounding a burn wound is referred to as burn wound progression, which remains 
clinically important but poorly understood” (Singh, Devgan et al., 2007). 
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Figure 2: Zones of Stasis in Burn Wound Conversion 
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A number of systemic and local factors and cellular mechanisms can be involved in 
burn wound conversion.  Local and systemic factors include infection, edema, altered 
perfusion caused by circumferential eschar, general health (e.g., age), shock, inadequate 
fluid resuscitation, cytokine alterations, and pathologies such as atherosclerosis, 
peripheral vessel disease, and diabetes. Edema, decreased fluid resuscitation, and 
altered perfusion can all cause cell death because of a drop in intravascular and 
interstitial fluid volumes. The alterations in cytokine levels increase the chances of 
infection. Diabetes can occur due to decreased metabolic function. General health is 
very important as well because with a compromised immune system due to age or 
lifestyle, the ability for the body to heal is reduced. Models that have been used to study 
factors that affect burn wound conversion have already showed that fluid resuscitation 
can turn a partial thickness burn into a full thickness burn. (Singh, Devgan et al., 2007) 
Molecular mechanisms that have been suggested to contribute to burn wound 
conversion are diverse but most are directly or indirectly related to inflammation.  
Prostaglandins are formed through the action of cyclooxygenase. Certain prostaglandins 
are inhibitors of platelet aggregation and serve to vasodilate, whereas others act as 
potent vasoconstrictors and promote aggregation of platelets. Alterations in prostanoid 
levels can lead to vasoconstriction and thus a reduction in perfusion. (Robson, 1979)  
Conversely, increased levels of nitric oxide and pro-inflammatory cytokines can cause 
vasodilation resulting in edema and tissue congestion (Rawlingson, 2003).  
In 1968, McCord and Fridovich proposed that the enzyme xanthine oxidase was the 
major source of free radicals that contributed to reperfusion injury. Altered peripheral 
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perfusion decreases the oxygen available to peripheral tissues that is required for 
adenosine triphosphate (ATP) production.  As ATP depletion occurs, the level of 
adenosine monophosphate (AMP) rises and, in turn, is catabolized to hypoxanthine.   
The return of molecular oxygen to previously ischemic tissues results in hypoxanthine 
serving as a substrate for xanthine oxidase. In a series of complicated reactions, 
hypoxanthine is converted to xanthine and ultimately to uric acid, and this process 
produces hydrogen peroxide and superoxide, deleterious oxygen-derived free radicals. 
(McCord & Fridovich, 1968) 
Another major source of reactive oxygen species (ROS) in burn trauma comes from 
activated neutrophils. Activated neutrophils produce a burst of free radicals (Basadre et 
al., 1988; Horton et al., 1996; Horton & Garcia, 1995; Mileski et al., 1991). This 
neutrophil-related function serves a significant protective mechanism by scavenging 
invading bacteria; however, with injury such as burn trauma, a burst of neutrophil-
produced free radicals in addition to xanthine oxidase activity, may result in 
overwhelming tissue damage.  Moreover, while burn trauma increases ROS production, 
this type of traumatic injury also impairs antioxidant defense mechanisms, rendering the 
burn subject more susceptible to oxygen free radical mediated injury. For example, 
numerous studies have shown that burn trauma alters non-enzymatic defense 
mechanisms including decreases in alpha tocopherol, and ascorbic acid. These 
endogenous antioxidant mechanisms protect membranes against lipid peroxidation, 
scavenge oxygen derived free radicals, and dissipate free radical energy. In addition, 
burn trauma alters enzymatic defense mechanisms including altered superoxide  
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dismutase levels, reduced catalase and reduced glutathione levels (Cynober et al., 1985; 
Demling et al., 1995; Demling and LaLonde, 1990a; Demling and LaLonde, 1990b; 
LaLonde et al., 1992; LaLonde et al., 1997a; LaLonde et al., 1997b; Nguyen et al., 
1993; Rai & Courtemanche, 1975; Sasaki et al., 1990). 
 Recent attention has focused on the hypothesis that the accumulation of reactive 
biochemical species such as oxygen derived free radicals and non-radicals such as 
hydrogen peroxide and nitric oxide promote and exacerbate the inflammatory response 
(Cain et al., 1999; Giroir et a., 1994).  Inflammation is a standard immediate response to 
inury, including burns.  Acute inflammation is a natural defense to skin trauma. Non-
specific inflammation activates cascades such a complement, prostaglandins, and then 
the migration of neutrophils. Burn wounds have been observed to produce the non-
specific inflammatory response, although it has not been proven. Mediators of the 
inflammatory response act locally and systemically. Cytokines produced in response to 
inflammation initiate the leukocyte response. Overproduction of cytokines can lead to a 
“domino effect” and the inflammatory response can become widespread leading to 
systemic inflammatory response syndrome, acute respiratory distress syndrome, or 
multiple organ dysfunction syndrome. Although there are many cell types involved in 
the inflammatory response, research on animal models has shown that neutrophils and 
macrophages tend to predominate the injured tissue. (Tyler, Watts et al., 2000; 
Dokumcu, Ergun et al., 2008) 
In addition to their ability to generate ROS, neutrophils possess several types of 
granules in which are packaged large amounts of degradative enzymes such as serine 
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proteinases (e.g., elastase and cathepsin G) and matrix metalloproteinases (e.g., MMP-8 
and MMP-9).  Although these enzymes and the associated respiratory burst are 
designed to aid in debridement of devitalized tissues and destruction of microbes there 
is a growing appreciation that an over exuberant response by neutrophils can lead to 
additional damage of tissues. (Yager & Nwomeh, 1999) 
 
Heme Oxygenase – 1  
 
As outlined in the preceding section, there is evidence that a number of local and 
molecular factors associated with inflammation are involved in burn wound conversion.  
Therefore, targeting the inflammatory response could provide a means for modulating 
conversion.  Heme oxygenases are very important in the response to injury by 
amplifying inflammation (Burger, Xiang et al., 2008). Being able to control heme 
oxygenase (HO) would be extremely beneficial to decreasing the effects of burn wound 
conversion. 
HO is the first and rate-controlling enzyme of the degradation of heme into iron, 
carbon monoxide, and biliverdin, the latter being subsequently converted into bilirubin. 
See Figure 3. Several positive biological effects exerted by this enzyme have gained 
attention.  Heme is a potent oxidant, removal of free heme from the area of a burn 
injury is likely to be beneficial.  Perhaps just as important, carbon monoxide and 
bilirubin have been attributed to possess anti-inflammatory, antiapoptotic, angiogenic, 
and cytoprotective functions. (Farombi & Surh, 2006) Experimentation conducted by 
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Burger studied the effects that HO-1 had on erythropoietin (EPO), which is a hormone 
that can protect the heart from ischemia and reperfusion. EPO was shown to induce 
expression of HO-1. Apoptosis was decreased by an increase in expression of HO-1. 
Burger showed that the “selective inhibition of HO-1 using chromatin mesoporphyrin 
(CrMP) significantly diminished the ability of erythropoietin to inhibit apoptosis.” HO-
1 appeared to introduce a protective role in regards to arthrosclerosis and endotoxemia. 
(Burger, Xiang et al., 2008) Thus, the physiological induction of HO-1 may be an 
adaptive and beneficial response to several possibly noxious stimuli, including heme 
itself, suggesting a potentially autoprotective and autodefensive role in burn wound 
pathology. 
There are two genetic isoforms: HO-1 and HO-2. HO-1 expression is inducible in 
virtually every cell type.  In contrast, HO-2 is expressed constitutively in a limited 
number of tissues   amino acids. (Farombi & Surh, 2006) HO – 1 binds to heme in a 1:1 
ratio.  HO-1 in humans portrays a flexible bihelical structure which encompasses the 
heme pocket. Expression of HO-1 is apparent in large concentrations in the spleen, 
liver, and bone marrow. Within cells HO is abundant in the endoplasmic reticulum. 
Studies have provided some evidence of HO expression in the plasma membrane and 
the nucleus. (Ryter, Alam et. Al, 2006) Under normal physiological conditions most 
other tissues express only very low levels of HO-1. 
HO-1 synthesis is greatly amplified in response to biological stress of the body and 
tissues and serves as a protective mechanism in response to many different stimuli. For 
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example, heat shock, oxidative stress, UV radiation, and hydrogen peroxide are all 
found to induce the synthesis of HO-1. Although outside stresses can influence the 
levels of HO-1 produced in the body, injury or infection caused by systemic stress can 
also bring about the cytoprotectant role of HO-1.  HO-1 is strongly activated by a 
number of proinflammatory agents. Devey studied ischemia reperfusion injury in the 
liver. HO-1 was observed to have anti-inflammatory actions and protect cells from 
oxidative injury. When HO-1 was deleted in mice, the animals were susceptible to 
hepatic ischemia reperfusion (Devey, Ferenbach et al., 2008). Most studies involving 
HO-1, even though involving different parts of the body, show that HO-1 is probably 
essential for maintaining cellular homeostasis in the body. Growth retardation, anemia, 
iron deposition, and vulnerability to stressful injury are all observed in HO-1 knockout. 
Animals presented as HO-1 knockout normally do not survive. (Poss & Tonegawa, 
1997)  In addition, a similar phenotype has been observed in the one reported instance 
of a human with HO-1 deficiency (Yachie, Niida et al., 1999). 
Heme oxygenases have become recognized as major protective proteins.  Increased 
expression of HO-1 has been shown to be effective in preventing or ameliorating 
pathologies associated with atherosclerosis, angioplasty, chronic allograft rejection, 
inflammatory lung disease, LPS-induced endotoxemia, and ischemia reperfusion injury.   
Degradation of heme not only reduces the oxidative potential within tissues, but the 
products generated by the degradation of heme have potent antioxidant, anti-
inflammatory, anti-proliferative, and anti-apoptotic properties.   
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Figure 3: Pathway of heme metabolism.  
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Figure 4: Example of Research Objective:  
(A) Immediately post burn: intervening space (IS); burn wound.  
(B) Seven days post wounding.   
(C) Seven days post wounding with treatment (Mahanjan et al., 2006) 
They used 1 x 2 cm burns with 0.5 cm IS. I want to increase the IS to 1 
cm.
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Methods and Materials 
 
Burn Wound Healing of Animals Protocol 
 
The expression and influence of HO-1 on burn wounds was tested using Wistar 
male rats (Harlan Sprague Dawley, Inc., Indianapolis, IN). The standard outbred rat 
weighed approximately 225 g. The animals were delivered to Sanger Hall and allowed 
to acclimate to the new surroundings for about a week. Twenty four hours prior to the 
wounding procedure 0.1 cc of 5 mg/kg CoPP or 0.2 cc of 30 µM/kg SnPP were 
administered to the animal via intraperitoneal (I.P.) injection. The oxygen tank regulator 
in the surgery room was checked in order to make sure it was full. Polyethylene glycol 
pads were heated to 39°C.  
On the day of the procedure, water was brought to 100°C and a thermometer 
was used to monitor the temperature. A brass template (brand) specially made to wound 
the rats was placed in the boiling water. Refer to Figure 4. The template was made with 
three brass prongs and a wooden handle. The prongs were spaced 0.5 cm apart and each 
prong was 2 cm in height and 1 cm in length. Refer to Figure 5. 
 Anesthesia was induced with 4-5% isofluorane at 1.0 Liter/min. Following 
induction, the animal was removed from the induction chamber and placed in a nose 
cone that provided 2% isofluorane at 0.5 Liter/min. A toe pinch was administered to 
ensure the animal was under anesthesia. The tail was marked with a black Sharpie for 
identification purposes, and 0.2 cc of 125 µg/µL buprenorphine administered 
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subcutaneously (s.c.) in the skin on the back of the animal above a rear leg.  Clippers 
were used to remove the hair from the upper trunk region of the animal. Chemical 
depiliation (Nair) was used to remove the remaining hair. Phosphate buffered saline 
(PBS) pH 5.0 was used to rinse the area and neutralize the chemical depilator. The skin 
was dried thoroughly.  
The brand was taken out of the 100°C water, briefly dried and applied to the 
skin for 45 seconds using the weight of the brand for pressure. This produced a 
reproducible full-thickness burn where the brand directly touched the skin.  In addition, 
the two interspace regions frequently also became necrotic.  In this model, the 
interspace region represents a zone of stasis. A labeled ruler tape was placed beneath 
the wound and a photograph was taken to document the brand. The animal was then 
placed in the recovery chamber for about 10-15 minutes or until walking around and 
alert, and then placed in appropriate cages. The procedure was documented on the data 
sheets. As follow up, the branded animals were given 0.2cc of 125 µg/mL 
buprenorphine twice a day for two days and then on days 3-7 (or until sacrificed) 
provided one “cherry Jello shot” containing 75 mg of acetaminophen.  
 On Day 1, 3, or 7 the animals were sacrificed (Euthasol (150 mg/kg, I.P.). and in 
the time it took for the Euthasol to take effect, the materials were collected: bucket of 
ice, 15 mL tubes labeled appropriately, “RNALater” (25 mM sodium citrate at pH 5.2 
and 25 mM EDTA), cutting board, scalpel blades, tweezers, surgical scissors, blue 
chucks, camera, and ruler tape. A picture of the wound was taken labeled with ruler tape 
before any surgical procedures were performed. A blue chuck was placed on the bench 
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and No. 15 scalpel blades used to remove the wound from the back of the animal. Then 
the wound was divided into: normal skin, not affected by the brand; direct burn; and the 
interspaces between each direct burn so, three samples were taken from each animal. 
See Table 1 for treatment groups. Each of these samples were harvested, minced into 
1.0 mm pieces, and placed in labeled 15 mL tubes. Two sets of tissues were generated. 
The first set of tubes was placed in a -70 °C. “RNALater” was added to the second set 
of tubes and the samples were stored in a -20°C freezer to later be used for molecular 
study.  
 
Tissue Extraction 
 
Proteins were extracted in manner that would be amenable for enzymatic and 
immunoblotting analyses.  The samples were taken out of the -70 °C freezer and 
approximately 100 mg of each sample was weighed out and placed into a 15 mL 
polypropylene round bottom tube. 2 mL of 1X Homogenization Buffer (25 mM Tris-Cl 
pH 7.5, 0.2 M NaCl, 3.0 mM CaCl2, 0.03% Brij-35) was added and the tissue was 
homogenized using a Brinkmann Polytron (PT 10/35) Homogenizer with a standard 
saw tooth generator (20 Mm dia).  The generator was rinsed with deionized water 
before homogenization began and in between each sample in order to prevent cross-
contamination. Each tissue sample was homogenized with about 15 to 20 second pulses. 
The processed samples were then transferred to 1.5 ml microfuge tubes and spun at 
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18,000g for 20 minutes at 4°C to clarify them. The clarified extract was then transferred 
to a new 1.5ml tube for use in various enzymatic assays. 
 
Protein Assay 
 
The protein concentration was determined using the Bio-Rad Assay. This assay 
used an acidic solution of Coomassie Brilliant Blue G-250 dye to determine the 
concentration of solubilized protein in the sample. The dye binds to the protein which 
shifts absorbance from 465 to 595 nm. The change in color of the dye occurs in 
response to different amounts of protein.  
 Standard and sample wells were all set up in a 96-well plate. The standard wells 
consisted of an increasing amount of bovine serum albumin (BSA), ranging from 2 g 
to 24 g.  Volumes were brought to 160 l with water and 1X Homogenization buffer.  
BioRad protein assay reagent (40 l) was added and mixed. Wells containing samples 
and standards contained identical amounts of the homogenization buffer to correct for 
artifactual contribution of the homogenization buffer to the absorbance.   The plate, 
with the samples and standards, was then incubated and read for 5 minutes at 595 nm 
using the uQuant spectrophotometer (Biotek Instruments, Inc., Winooski, VT). A 
standard curve with a correlation of 0.9 or better was considered acceptable.  
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Myeloperoxidase Assay 
 
During the acute phase of inflammation, neutrophils leave the vasculature and 
travel towards the site of inflammation by chemotaxis (Broughton, Janis et al., 2006). 
Myeloperoxidase (MPO) is a lysosomal enzyme most abundantly located in the 
cytoplasmic granules of neutrophils. This enzyme accounts for 5% of the total protein 
of neutrophils and approaches 25% of the protein within the granules themselves.  
Monocytes also express MPO, but these cells are much less abundant than neutrophils 
and express less MPO per cell than neutrophils.  Therefore, this enzyme is typically 
regarded as a marker of neutrophils. This enzyme is synthesized as a single chain 
precursor developed into a tetramer consisting of two light chains and two heavy chains 
bound to a prosthetic heme group.  MPO catalyzes the reaction of hydrogen peroxide 
with chloride ions to form hypochlorous acid (HClO). (Lau, Mollnau et al., 2004; 
Mathy-Hartert, Bourgeois et al., 1998)   
 
The primary reaction in the MPO assay is: 
 
 
 
The MPO Assay uses –dianisidine dyhydrochloride (AH2) as the hydrogen 
donor, which combines with the oxygen radical produced from the breakdown of 
hydrogen peroxide. After this occurs, a colored compound is formed (A) which can be 
H2O2               H2O + O- 
 
O- + AH2              H2O + A 
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followed spectrophotometrically to quantify the amount of myeloperoxidase in the 
tissue samples. 
The uQuant spectrophotometer (Biotek Instruments, Inc., Winooski, VT) using 
KC Junior software was turned on about twenty minutes prior to use. The reagents 
needed were: stock MPO (Calbiochem) stored with 100 µg of MPO in 850 µL of PBS, 
0.2 M Phosphate Buffer, and 50 mM Phosphate Buffer, hexadecyltrimethyl -ammonium 
bromide (HTAB), hydrogen peroxide, 800 µM  – dianisidine dyhydrochloride. 85 µL 
aliquots of MPO were removed from the -20°C as 23.5 milliunits per µL. At pH 6.0 and 
25°C one unit reduces 1 µM of hydrogen peroxide per minute. The stock MPO was 
diluted to 0.2 milliunit/µL. Specific amounts of MPO were added to each well of a 96 
well plate. The samples were thawed and diluted to 30 µg of protein in a final volume of 
150 µL of HTAB. HTAB is a detergent that was used to lyse the polymorphonuclear 
(PMNs) neutrophils. The protein assay was used to determine the amount of protein 
present in each sample. Since 5 µL of each samples were used in the protein assay, the 
amount of protein determined was taken and divided by 5 µL. In order to dilute the 
samples to 30 µg of protein in 150 µL of HTAB, 30 µg was divided by the 
concentration previously determined. These calculations gave the amount (µL) of 
sample needed to add to the wells. Then 50 µL of the samples with HTAB were added 
to the wells. 0.25 mg of  – dianisidine dyhydrochloride was dissolved in 1 mL of 50 
mM Phosphate Buffer and 50 µL was dispensed into the wells. The plate reader was set 
so that kinetic reads were taken at 5 minute intervals (12 readings) at 450 nm. Lastly, 50 
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µL of 0.01% hydrogen peroxide was mixed with the contents of the wells using a multi-
pipettor, so as to read the plate as quickly as possible due to the fast reaction. 
 
Concentration of Protein Samples Using Trichloroacetic Acid 
 
 It was necessary to further concentrate some extracts.  This was accomplished 
by precipitating samples with trichloroacetic acid (TCA).  The reagents needed were: 
100% TCA, 20% TCA, and 100% ethanol. The amount of the sample to be placed in a 
1.5 mL tube was determined from the protein assay. An equal volume of 20% TCA was 
added to the sample and mixed. The sample with TCA was left in the -20°C freezer for 
twenty minutes. The tubes were then spun at 4°C in the microcentrifuge at maximum 
speed for 15 minutes. The supernatant was carefully removed and discarded and the 
pellet retained. Washing of the pellet was accomplished by adding 100 µL of ice-cold 
100% ethanol. The tube was inverted a couple of times and microfuged for 5 minutes 
just to ensure that the pellet was adhered to the bottom of the tube. The ethanol was then 
pipetted out. The pellet was air dried in Dryer in the cold room for 5 minutes. 6X 
Reducing Loading buffer used in the Western blot was diluted to 2X Loading Buffer. 
The sample was then resuspended in 36 µL of the 2X Loading Buffer. 6X Reducing 
Loading Buffer is composed of 3 mL [2M] of 600 mM Tris pH 6.8, 3 mL [20%] of 
6.0% sodium dodecyl sulfate (SDS), 3 mL of 30% glycerol, 629 µL of 900 mM 
dithiothreitol (DTT), 500 µL [1%] of 0.05% N,N-bis(2-pyridinecarboxamide)-1,2-
benzene dianion (BpB), q.s. to 10 mL H2O. 
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Immunoblotting (Western) Using Traditional Gel System 
 
Polyacrylamide gels form after monomeric acrylamide is polymerized. N, N’-
methylenebisacrylamide cross-links chains. Ammonium persulfate (AP) initiates this 
reaction and tetramethylethylenediamine (TEMED) speeds it up. In discontinuous 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), the samples 
loaded first enter the stacking gel which contains chloride ions that migrate quickly. The 
electrophoresis buffer contains glycine, which are less mobile. A zone is generated 
during electrophoresis that has low conductivity and therefore a high voltage gradient. 
This results in stacking of proteins between the leading and trailing ions. SDS binds 
most proteins in a constant weight ratio. Therefore, SDS-protein complexes migrate 
through the gel according to their size. A 10% gel was used in this case because this 
was appropriate for the observation of heme oxygenase.  
The reagents needed were: 4X Stacking Gel Solution, 4X Resolving Gel 
Solution, 10X SDS-PAGE Running Buffer, 10% AP, 30% Bis-acrylamide stock, 
TEMED, 6X Loading Buffer, 10X Electroblotting Buffer, 10X Tris buffered saline 
Tween-20 (TBST), lowfat dried milk, primary antibody, secondary antibody, and 
chemiluminescence reagents (Perkin Elmer Lightning). 4X Stacking Gel solution is 
made up of 0.5 M Trizma Base, 0.4% SDS, and deionized water. 4X Resolving Gel 
solution is composed of 1.5 M Trizma Base, 0.4% SDS, and deionized water. 6X 
Loading Buffer consists of 600 mM Tris pH 6.8, 6.0% SDS, 30% glycerol, 900 mM 
DTT, 0.05% BpB, and deionized water. 10X Electroblotting Buffer is formed from 250 
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mM Trizma Base, 1.92 M glycine, and deionized water. Lastly, 10X TBST is created 
from 1.37 M NaCl, 200 mM Tris, 1% Tween, deionized water, and HCl to bring TBST 
to pH 7.6. 
The resolving gel was made using a 1.5 mm (10 cm x 10 cm) 10% 
polyacrylamide gel. A traditional (dimensions including thickness 1.5mm) glass 
cassette and casting stand assembly were set up. The resolving gel monomer solution 
was prepared by combining all the reagents: 4.2 mL of deionized water, 3.3 mL of 30% 
acrylamide, 2.5 mL of 4X Resolving Gel Solution, and 50 µL of 10% AP, except for the 
TEMED. 1 mL of the resolving gel solution was transferred to a 1.5 mL tube and 25 µL 
of TEMED was added. Immediately 0.5 mL of the solution was poured into the 
assembled gel cassette acting as a plug to ensure that there were no leaks. 
Polymerization occurred in about 5 minutes. Then 25 µL was added to the remaining 
monomer solution and 6.7 mL was pipetted into the gel cassette and 1 mL of deionized 
water was overlaid on top of the poured resolving gel solution by dialing down of the 
1000 µL pipette. The gel polymerized in about 15 minutes to 30 minutes.  
While the resolving gel polymerized, the 4% stacking gel solution was prepared 
by combining: 3.1 mL deionized water, 0.7 mL 30% acrylamide, 1.25 mL 4X Stacking 
Gel Solution, and 25 µL 10% AP. Before adding the 25 µL of TEMED the solution was 
vacuumed for 5 minutes in order to eliminate oxygen to expedite polymerization. When 
polymerization of the resolving gel took place, the water on top of the gel was poured 
off and replaced with the stacking gel solution. After the stacking gel solution was 
poured, the combs were put into place. The stacking gel was allowed to polymerize for 
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about 30-45 minutes. Once polymerization had taken place, the combs were gently 
removed and placed in the assembled gel cassette into the Electrophoresis Module. The 
tank was filled with 1X Running Buffer. The wells were rinsed thoroughly with the 1X 
Running Buffer prior to loading.  
Using the protein assay concentrations of the samples, 30 µg of each sample was 
transferred to a 1.5 mL tube and each sample brought to 30l with deionized water. 6X 
Loading Buffer (6l) was added and mixed. The samples were then heated at 95°C for 
5-7 minutes in a Perkin-Elmer Thermocycler. 4-6 µL of Bio-Rad Prestained protein 
markers were loaded into the first lane. 30 µL of each sample was added to each 
remaining well. The lid was placed on the tank, making sure that the electrodes matched 
in color. The power supply was turned on and run at a constant voltage of 100 V. The 
gel ran for about 90 minutes or until blue dye reached the bottom of the gel.  
The electrophoresis cassette was disassembled and in a 9 inch Pyrex dish filled 
with 1X Electroblot Buffer, the plates of the gel were pried apart and using a metal 
spatula the gel was removed from the glass plates. Sponges and filter paper were 
allowed to prewet in the 1X Electroblot Buffer. The Transblot cassette was placed in a 
second 9 inch Pyrex dish and immersed black side down in the remaining 1X 
Electroblot Buffer. On the black side of the cassette, a sponge, one paper filter, gel, 
polyvinylidene fluoride (PVDF) transfer membrane, one paper filter, and one sponge 
were set up. The PVDF membrane was first dipped in methanol due to the membrane 
being highly hydrophobic. The cassette was then placed into the transblot tank that 
contained an ice pack and a stirring bar. The transblot tank was set on a magnetic plate 
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and filled almost to the top with 1X Electroblot Buffer. The lid was put on and the 
electrodes were plugged into the power supply. The power supply was set to constant 
current at 400 mA with the unit producing about 100-125 V. The transfer went for 1 
hour. The cassette was removed and the side of the membrane touching the gel was 
labeled with a soft lead pencil. The two pink bands of the marker were labeled and a 
form of ID was written on the membrane.  
The membrane was blocked for 1 hour at room temperature with continual 
agitation with about 20 mL of 5% milk in 1X TBST. From this point on the membrane 
never became dry. The block was removed and rinsed quickly with 1X TBST. The 
primary antibody was diluted appropriately in 1X TBST and approximately 10 mL was 
added to the membrane. The membrane in the primary antibody was then incubated 
overnight at 4°C with continual rocking.  
The next day the primary antibody was removed and stored at -20°C freezer and 
was reused several times. The membrane was washed in 1X TBST four times for 5 
minutes each with 25-50 mL of 1X TBST. During the washes, the secondary antibody 
was diluted appropriately in 1X TBST and added to the membrane. The membrane was 
incubated in the secondary antibody at room temperature with continual rocking for 1 
hour. The secondary antibody was removed and discarded. The membrane was again 
washed in 1X TBST 4 times for 5 minutes each. During the final wash, 5 mL of each of 
the Perkin Elmer luminal and substrate solutions were mixed (total 10 mL). After the 
last wash, the membrane was immersed in the luminal and substrate solution. 
Immediately following, the membrane was wrapped in plastic wrap and placed in a film 
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cassette with fluorescent crayon labels. The membrane was exposed to autorad film for 
5-30 minutes and developed.  
 
Gelatin Zymography 
 
Gelatin zymography was used to reveal the presence of the matrix 
metalloprotienases (MMP), MMP-2 and MMP-9. Gelatinases are resolved by SDS-
PAGE, after renaturing, the gelatinases degrade the gelatin substrate that was 
copolymerized into the gel. Staining with Coomasie Blue results in clear zones on the 
gel in the midst of a dark background. The zones of clearing represent areas in which 
the gelatin was degraded.   
The reagents needed were: 4X Stacking Gel Solution, 4X Resolving Gel 
Solution, 10X SDS-PAGE Running Buffer, 10% AP, 30% Bis-acrylamide stock, 
10mg/mL Gelatin, TEMED, 6X Non-Reducing Loading Buffer, 2.5% Triton X-100, 
10X MMP Buffer, 0.1% Coomasie Blue, and 10% acetic acid-10% ethanol. 
The resolving gel was made using a 1.5 mm (10 cm x 10 cm) 10% acrylamide 
gel. A traditional glass cassette and casting stand assembly were set up. The resolving 
gel monomer solution was prepared by combining all the reagents: 3.2 mL of deionized 
water, 3.3 mL of 30% acrylamide, 2.5 mL of 4X Resolving Gel Solution, 1.0 mL of 10 
mg/mL Gelatin, and 50 µL of 10% AP, except for the TEMED. 1 mL of the resolving 
gel solution was transferred to a 1.5 mL tube and 25 µL of TEMED was added. 
Immediately 0.5 mL of the solution was poured into the assembled gel cassette acting as 
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a plug to ensure that there were no leaks. Polymerization occurred in about 5 minutes. 
Then 25 µL of TEMED was added to the remaining monomer solution and 6.7 mL was 
pipetted into the gel cassette and 1 mL of deionized water was overlaid on top of the 
poured resolving gel solution by dialing down of the 1000 µL pipette. The gel 
polymerized in about 15 to 30 minutes.  
While the resolving gel polymerized, the 4% stacking gel solution was prepared 
by combining: 3.1 mL deionized water, 0.7 mL 30% acrylamide, 1.25 mL 4X Stacking 
Gel Solution, and 25 µL 10% ammonium persulfate. Before adding the 25 µL of 
TEMED the solution was vacuumed for 5 minutes in order to eliminate oxygen to 
expedite polymerization. When polymerization of the resolving gel took place, the 
water on top of the gel was poured off and replaced with the stacking gel solution. After 
the stacking gel solution was poured, the combs were put into place. The stacking gel 
was allowed to polymerize for about 30-45 minutes. Once polymerization had taken 
place, the combs were gently removed and placed in the assembled gel cassette into the 
Electrophoresis Module. The tank was filled with 1X Running Buffer. The wells were 
rinsed thoroughly with the 1X Running Buffer prior to loading.  
 Using the protein assay concentrations of the samples, 30 µg of each sample was 
transferred to a 1.5 mL tube and each sample had the appropriate amount of deionized 
water added, so that the same volume was added to each well. Then 1/5 volume of 6X 
Non- Reducing Loading Buffer was added. 4-6 µL of Bio-Rad Prestained protein 
markers were loaded into the first lane with 26 µL of tissue sample chosen due to high 
levels of protein. This addition of the same tissue sample with marker to each gel 
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allowed for a normalization of gel to gel variations. 30 µL of each sample was added to 
each remaining well. The lid was placed on the tank, making sure that the electrodes 
matched in color. The power supply was turned on and run at a constant voltage of 100 
V. The gel ran for about 90 minutes or until blue dye reached the bottom of the gel.  
 The electrophoresis cassette was disassembled and in a 9 inch Pyrex dish filled 
with 2.5% Triton X-100, the plates of the zymogram were pried apart and using a metal 
spatula the zymogram was removed from the glass plates. A notch was made in the top 
corner of the zymogram that contained the marker. Notches were also made at the pink 
bands from the marker. Then the zymograms were incubated in the 2.5% Triton X-100 
for 30 minutes each at room temperature on the rocker. This incubation was done twice. 
10 X MMP Buffer was diluted to 1X MMP Buffer which consisted of 25 mM Tris –Cl 
pH 7.5, 200 mM NaCl, 3 mM CaCl2, and 0.3% Brij – 35. 1X MMP Buffer was used to 
incubate the zymogram overnight at 37°C on the rocker.  
 The zymogram was removed from the 1X MMP Buffer and stained with 0.1% 
Coomasie Blue in 10% acetic acid and 10% ethanol for 2-4 hours on the rocker at room 
temperature. Destaining was done with 10% acetic acid-10% ethanol for about 1-2 
hours on the rocker at room temperature. Kim-Wipes were placed in the corner of the 
containers in order to speed up the destaining process. When zones of clearing were 
very apparent, the zymogram was removed from the destaining solution and a picture 
was taken using a digital camera. The settings of the digital camera were consistent 
throughout the documenting of the zymograms: macro setting, no flash, and ISO 200 
using a light box. 
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Assay for Collagenolytic Activity 
 
Collagen consists of a triple helical structure. Active collagenase is an enzyme 
that cleaves collagen. Collagenase breaks collagen into two TCA fragments. Above 
30°C the two fragments of collagen will denature. This particular assay shows the two 
fragments on the gel due to utilization of radioactive collagen. Fluorography is used for 
detecting the radioactive labeled collagen activity in the assay. Radiation is emitted 
from substances in this case collagen that are radioactively labeled. This radiation 
excites a molecule, also known as a fluor, in the gel. The excited fluor then relaxes back 
down to the ground state and emits a photon of visible light that is detected by a film. 
Then the film is developed and the bands are portrayed. This technique allows for 
increased sensitivity to weak radiation signals. (Waterborg et al., 1994; Laskey, 2003)  
The reagents needed were: dialyzed 14C labeled collagen (Type I), 10X MMP 
Buffer, 500 mM EDTA, 50 mM aminophenylmercuric acetate (APMA) made fresh in 
0.1 N NaOH, 6% SDS-PAGE gel, 6X Reducing Loading Buffer, 10% acetic acid-10% 
ethanol, and Amplify.  
Master mixes were set up on ice using 0.5 mL microfuge tubes. There were 
three tubes per sample: negative, active, and total. The negative contained 30 µL of 1X 
MMP Buffer, 20 µL of sample, 2 µL of ethylenediamene tetraacedic acid (EDTA), and 
50 µL of 14C-collagen. The active contained 30 µL of 1X MMP Buffer, 20 µL of 
sample, and 50 µL of 14C-collagen. The total contained 30 µL of 1X MMP Buffer, 20 
µL of sample, 3 µL of aminophenylmercuric acetate (APMA), and 50 µL of 14C 
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-collagen. Once these samples were prepared, they were placed in the Thermocycler at 
30°C for 1 hour, 4 hours, and overnight. After 1 hour a 30 µL aliquot was taken out and 
added to a new tube containing 6 µL of 6X Reducing Loading Buffer to stop the 
reaction. This same aliquot was done after 4 hours and then overnight. The tubes taken 
out after 1 hour and 4 hours were then stored at -20°C until the last aliquot was 
collected. When all the aliquots were ready to be run, a 6% SDS-PAGE gel was made.  
The resolving gel was made using a 1.5 mm (10 cm x 10 cm) 6% acrylamide 
gel. A traditional glass cassette and casting stand assembly were set up. The resolving 
gel monomer solution was prepared by combining all the reagents: 5.5 mL of deionized 
water, 2.0 mL of 30% acrylamide, 2.5 mL of 4X Resolving Gel Solution, and 50 µL of 
10% AP, except for the TEMED. 1 mL of the resolving gel solution was transferred to a 
1.5 mL tube and 25 µL of TEMED was added. Immediately 0.5 mL of the solution was 
poured into the assembled gel cassette acting as a plug to ensure that there were no 
leaks. Polymerization occurred in about 5 minutes. Then 25 µL was added to the 
remaining monomer solution and 6.7 mL was pipetted into the gel cassette and 1 mL of 
deionized water was overlaid on top of the poured resolving gel solution by dialing 
down of the 1000 µL pipette. The gel polymerized in about 15 to 30 minutes.  
While the resolving gel polymerized, the 4% stacking gel solution was prepared 
by combining: 3.1 mL deionized water, 0.7 mL 30% acrylamide, 1.25 mL 4X Stacking 
Gel Solution, and 25 µL 10% ammonium persulfate. Before adding the 25 µL of 
TEMED the solution was vacuumed for 5 minutes in order to eliminate oxygen to 
expedite polymerization. When polymerization of the resolving gel took place, the 
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water on top of the gel was poured off and replaced with the stacking gel solution. After 
the stacking gel solution was poured, the combs were put into place. The stacking gel 
was allowed to polymerize for about 30-45 minutes. Once polymerization had taken 
place, the combs were gently removed and placed in the assembled gel cassette into the 
Electrophoresis Module. The tank was filled with 1X Running Buffer. The wells were 
rinsed thoroughly with the 1X Running Buffer prior to loading.  
The samples were heated at 95°C for 5 minutes and run on the gel with 30 µL of 
sample per well using 4-6 µL of marker in Lane 1 only. The gel was electrophoresed at 
100 V for about 45 minutes. The gels were removed from the glass and fixed in 10% 
acetic acid-10% ethanol for 10-15 minutes at rocker on room temperature or until the 
dark blue band at the bottom of the gel turned a yellow color. The gels were then 
incubated in about 25 mL of Amplify for 20 minutes on the rocker at room temperature. 
About 45 minutes prior to gel drying, the gel dryer was turned on. The gels were placed 
on two sheets of filter paper, covered with saran wrap, and placed on the dryer for 1 
hour. Immediately following, the gel was wrapped in plastic wrap and placed in a film 
cassette with fluorescent crayon labels. The gel was exposed to film for about 2 days in 
the -70°C freezer and developed. 
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Figure 4: Template for Burn Wound 
Template for Burn 
Induction 
1.0cm 1.0cm 
Non-thermo conducting 
(e.g., wood)handle 
2.0cm 
Thermocouple 
(optional) 
5.0cm 
5.0cm 
Machined 
Aluminum 6061 T6 
0.375” by 0.75” 
Long and short strips that 
are screwed together? 
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Table 1: Treatment Groups for Burn Wounding 
 
 
 
Treatment Groups 
Groups Treatment Day 1 Day 3 Day 7 
1 Burned, untreated N=8 n=7 n=7 
2 Burned, 5mg/kg CoPP N=8 n=7 n=7 
3 Burned, 30M/kg SnPP N=7 n=7 n=9 
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Results 
 
Surgery and Animal Survival 
 
Full-thickness thermal injury was generated using an established procedure with 
some modification (Ehrlich et al., 1992).  In the original model, a brass probe consisting 
of a 55 x 19 mm rectangle with three 5 mm wide transverse notches was used to 
generate a row of four 10 x 19 mm full-thickness burns.  Because of the size of this 
probe, it was found to be difficult to achieve a relative uniform burn.  Therefore, the 
probe used in this study was modified to consist of a 40 mm x 20mm rectangle 
containing two 5 mm-wide transverse notches. 
A pilot was performed on a small group of animals to establish optimal contact 
time required for obtaining a reproducible full-thickness thermal injury with minimal 
involvement of the underlying muscle.  Animals were anesthetized with inhalant 
isoflurane and provided buprenorphine analgesia subcutaneously (sc).   A rectangular 
brass probe was equilibrated to 100°C.  The heated probe was applied to the depilated 
back of the anesthetized animals.  Probes were allowed to “balance” on the skin for 30, 
35, 40, and 45 seconds before removing.   The wounds were examined on days post 
wounding 1 and 3.  It was determined that application of the probe for 45 seconds 
achieved the desired burn severity.  This procedure was used on all 54 animals in this 
study.  Mortality was less than 2% (1/54).  The total surface area of the burn injury was 
less than 4% of total body surface area. 
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On some occasions, while using the Nair product to eliminate the rats’ hair prior 
to injury, all the hair was not completely removed. This could have had a slight effect 
on the small differences between burn wounds.  
The rats were examined twice daily and to provide analgesia. All of the animals 
appeared normal, alert, and experiencing little pain given that pain medications were 
administered daily. Documentation of the injury on the animals was made daily. The 
majority of the animals did not seem to aggravate their wounds and only very few 
appeared to be worse after healing should have already set in. A picture was taken 
immediately after each animal was injured.  Wounds were also photo-documented on 
sacrifice Day 1, Day 3, and Day 7 following injury.  See Figure 6. Following euthansia, 
normal skin, skin subjected to direct application of the probe (direct) and skin 
representing the interspace was harvested.  Tissues were bisected with portions snap 
frozen and stored at  -70°C or placed in “RNALater” and stored at -20°C.  
 
Measurement of Burn Conversion 
 
Areas of necrosis within the interspace regions of wounds taken at harvest were 
determined by planimetry using SigmaScan.  Each photograph was calibrated using a 
size reference placed on each wound.   Areas of frank necrosis were then determined.  
As can be seen in figure 7, in general, wounds in animals treated with Co PP contained 
smaller areas of frank necrosis than either the Sn PP or untreated groups.  For the Co PP 
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treated group, there was a statistically significant difference (p<0.05, ANOVA, Tukeys) 
on days 3 and 7 compared to either of the other two groups. 
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Figure 6:  Representative Burns on Days 0, 1, 3, and 7 Post Wounding
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Figure 7:  Mean Levels of Necrosis
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BCA Assay for Protein Concentration 
 
Tissues were thawed on ice and then extracted as described in the Methods.  
Concentrations of protein extracts were determined using the bicinchoninic acid protein 
assay using bovine serum albumin to generate a standard curve.  This assay has been 
adapted to a 96-well format to minimize consumption of materials. The protein standard 
curve shown in figure 8 on page 42 was very accurate from 2 – 24 µg. There was one 
point (under 2 µg) on the standard curve that appeared to not be consistent with the rest 
of the points, but when taking that specific point out; the R-squared value became 
0.9894. R2 = 1 is considered to be a perfect standard curve. This assay showed that there 
was an abundant amount of protein in the samples. By ensuring that protein was in each 
sample, the multitudes of subsequent tests were able to be performed. 
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Figure 8: Protein Assay Standard Curve Generated from Tissue Samples; the curve was 
linear between 2 and 24 µg of protein 
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 Western Blot for Heme Oxygenase - 1 Levels 
 
The heme oxygenase – 1 protein levels were determined using immunoblotting. 
HO-1 migrated as a 32 kDa  protein. A composite of HO-1 expression on Day 1 is 
shown in figure 9.  In animals not treated with heavy metal protoporphyrins there is no 
detectable expression of HO-1 in non-burned skin.  In contrast there is significant 
expression of HO-1 in the interspace region.  This was expected as HO-1 is a stress 
response protein.  Typically, there were lower levels of HO-1 present in tissues 
representing full-thickness burns.  As these tissues are nonviable, this was an expected 
outcome.  HO-1 expression in tissues from animals treated with either heavy metal 
protoporphyrin revealed a significantly different pattern. As expected, heavy metal 
protoporphyrins induced global expression of HO-1.  Somewhat unexpectedly, HO-1 
levels were consistently higher in tissues from animals treated with Co PP than with Sn 
PP (Figures 10-12).  In vitro studies in this laboratory have demonstrated that carbon 
monoxide, one of the products generated by HO-1, can act in a positive feedback 
manner on HO-1 expression (Kulina, R., 2008).  Thus, the higher levels observed in 
animals treated with Co PP may be explained by this.  A less likely explanation is that 
Co PP’s ability to inhibit necrosis may in turn permit greater expression of HO-1.  
However, the differential response to the heavy metal protoporphyrins is observed in 
non-burned tissues (Figure 11). Statistical analysis was achieved using the program, 
SigmaStat. ANOVA (Tukeys) tests were performed for direct burn tissue, non-burned 
tissue, and interspace tissue. See Tables 2-4. 
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  Beginning with tissue samples from the directly burned skin on Day 1 and Day 
3 showed similar results. Cobalt PP HO – 1 levels were the highest, while in the control 
groups, the lowest levels were observed. Tin PP showed HO – 1 levels mid – range and 
the untreated animals had the lowest levels of HO – 1. The amount of HO – 1 was 
greater in every group on Day 3 compared to Day 1. The final surgery day, Day 7, 
showed the cobalt PP group with the highest levels of HO – 1, which appears to be very 
consistent. The untreated group has fairly high levels of HO – 1. Lastly, the tin PP 
treated animals had the lowest amount of HO – 1.  
Skin tissue samples (uninjured tissue) on Day 1, the animals treated with cobalt 
PP had the highest level of HO – 1. Untreated animals had the lowest concentration of 
HO – 1 and the animals treated with tin PP also had very low levels. Day 3 skin HO – 1 
level was again highest in cobalt PP and lowest in non – treated animals. The HO – 1 
level for Tin PP were slightly higher than those for Day 1, but again low. Lastly, the HO 
– 1 levels for skin Day 7 again had cobalt PP treated animals with the highest 
concentration, but tin PP with the lowest concentration. The non – treated animals had 
an increase compared to Day 1 and Day 3.  
 The interspace tissue samples for Day 1 and Day 3 show the highest level of 
heme oxygenase – 1 in the tissue treated with cobalt PP. The lowest level of HO – 1 is 
apparent in the control group and tin PP HO – 1 levels ranged in the middle of the 
control and cobalt PP treated animals.  Although, Day 3 tin PP HO – 1 levels were 
slightly higher than those of Day 1. The interspace samples for Day 7 were slightly 
different. The tissue treated with cobalt PP again had the highest level of HO – 1. Tin 
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PP had the lowest level of HO – 1 and the untreated animals showed the middle range 
of HO – 1 levels.  
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Figure 9: Representative Immunoblots of HO-1 Protein Expression 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Representative Immunoblot - HO-1 Protein Expression on Day 1
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Figure 10: HO-1 Protein Levels in Full-thickness Burns 
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Table 2: Statistical Analysis (ANOVA) for HO-1 Levels in Direct Burn Tissues 
One Way Analysis of Variance Thursday, December 11, 2008, 19:26:45 
 
Data source: Data 1 in Notebook 
 
Normality Test: Passed (P = 0.061) 
 
Equal Variance Test: Failed (P = 0.035) 
 
 
Test execution ended by user request, ANOVA on Ranks begun 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks Thursday, December 
11, 2008, 19:26:45 
 
Data source: Data 1 in Notebook 
 
Group   N Missing  
Control Day 1   8  0  
Cobalt Day 1   8  0  
Tin Day 1   7  0  
Control Day 3   7  0  
Cobalt Day 3   7  0  
Tin Day 3   7  0  
Control Day 7   7  0  
Cobalt Day 7   7  0  
Tin Day 7   6  0  
 
Group   Median 25%  75%  
Control Day 1  8397.000 3072.000 14675.500  
Cobalt Day 1  68063.500 42127.500 108685.000  
Tin Day 1  27057.000 16770.250 39450.500  
Control Day 3  4042.000 1992.750 8368.750  
Cobalt Day 3  43827.000 20439.250 50667.250  
Tin Day 3  13265.000 9340.500 39747.750  
Control Day 7  68678.000 30986.000 78767.000  
Cobalt Day 7  84808.000 81665.000 91055.500  
Tin Day 7  40430.000 32044.000 54506.000  
 
H = 39.032 with 8 degrees of freedom.  (P = <0.001) 
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The differences in the median values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference (P = <0.001) 
 
To isolate the group or groups that differ from the others use a multiple comparison 
procedure. 
 
All Pairwise Multiple Comparison Procedures (Dunn's Method): 
 
Comparison    Diff of Ranks p Q P<0.05 
Cobalt Day 7 vs Control Day 3 45.429   9 4.565 Yes  
Cobalt Day 7 vs Control Day 1 43.196   8 4.483 Yes  
Cobalt Day 7 vs Tin Day 3  31.429   7 3.158 No  
Cobalt Day 7 vs Tin Day 1  29.429   6 2.957 No Test Needed 
Cobalt Day 7 vs Tin Day 7  23.238   5 2.243 No Test Needed 
Cobalt Day 7 vs Cobalt Day 3 21.000   4 2.110 No Test Needed 
Cobalt Day 7 vs Control Day 7 14.143   3 1.421 No Test Needed 
Cobalt Day 7 vs Cobalt Day 1 8.196   2  0.851 No Test Needed 
Cobalt Day 1 vs Control Day 3 37.232   8 3.864 Yes  
Cobalt Day 1 vs Control Day 1 35.000   7 3.760 Yes  
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Figure 11: HO-1 Protein Levels in Unburned Skin 
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Table 3: Statistical Analysis (ANOVA) for HO-1 Levels in Unburned Tissues 
One Way Analysis of Variance Thursday, December 11, 2008, 19:46:21 
 
Data source: Data 1 in Notebook 
 
Normality Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, ANOVA on Ranks begun 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks Thursday, December 
11, 2008, 19:46:21 
 
Data source: Data 1 in Notebook 
 
Group   N Missing  
Control Day 1   8  0  
Cobalt Day 1   8  0  
Tin Day 1   7  0  
Control Day 3   7  0  
Cobalt Day 3   7  0  
Tin Day 3   7  0  
Control Day 7   7  0  
Cobalt Day 7  7  0  
Tin Day 7   6  0  
 
Group   Median 25%  75%  
Control Day 1  1673.000 1148.000 3236.500  
Cobalt Day 1  84846.500 73776.000 87035.000  
Tin Day 1  6999.000 3667.500 12697.750  
Control Day 3  830.000 459.500 2020.750  
Cobalt Day 3  23963.000 5013.250 31789.000  
Tin Day 3  5255.000 2406.250 9653.500  
Control Day 7  15304.000 6636.250 25079.250  
Cobalt Day 7  47388.000 36323.000 62480.500  
Tin Day 7  1672.500 0.000  3437.000  
 
H = 45.610 with 8 degrees of freedom.  (P = <0.001) 
 
The differences in the median values among the treatment groups are greater than 
would be expected by chance; there is a statistically significant difference (P = <0.001) 
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To isolate the group or groups that differ from the others use a multiple comparison 
procedure. 
 
All Pairwise Multiple Comparison Procedures (Dunn's Method): 
 
Comparison    Diff of Ranks p Q P<0.05 
Cobalt Day 1 vs Control Day 3 47.393   9 4.918 Yes  
Cobalt Day 1 vs Control Day 1 42.500   8 4.565 Yes  
Cobalt Day 1 vs Tin Day 7  42.250   7 4.202 Yes  
Cobalt Day 1 vs Tin Day 3  31.821   6 3.302 Yes  
Cobalt Day 1 vs Tin Day 1  25.393   5 2.635 No  
Cobalt Day 1 vs Cobalt Day 3 21.107   4 2.190 No Test Needed 
Cobalt Day 1 vs Control Day 7 18.250   3 1.894 No Test Needed 
Cobalt Day 1 vs Cobalt Day 7 6.679   2  0.693 No Test Needed 
Cobalt Day 7 vs Control Day 3 40.714   8 4.091 Yes  
Cobalt Day 7 vs Control Day 1 35.821   7 3.717 Yes  
Cobalt Day 7 vs Tin Day 7  35.571   6 3.434 Yes  
Cobalt Day 7 vs Tin Day 3  25.143   5 2.526 No  
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Figure 12: HO-1 Protein Levels in Interspace Tissues 
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Table 4: Statistical Analysis (ANOVA) for HO-1 Levels in Interspace Tissue 
One Way Analysis of Variance Thursday, December 11, 2008, 20:10:49 
 
Data source: Data 1 in Notebook 
 
Normality Test: Passed (P = 0.168) 
 
Equal Variance Test: Passed (P = 0.062) 
 
Group   N Missing  
Control Day 1   8  0  
Cobalt Day 1   8  0  
Tin Day 1   7  0  
Control Day 3   7  0  
Cobalt Day 3   7  0  
Tin Day 3   7  0  
Control Day 7   7  0  
Cobalt Day 7   7  0  
Tin Day 7   6  0  
 
Group   Mean  Std Dev SEM  
Control Day 1  19666.000 12095.603 4276.441  
Cobalt Day 1  52713.750 29197.309 10322.808  
Tin Day 1  34347.143 18103.927 6842.641  
Control Day 3  4236.571 4643.180 1754.957  
Cobalt Day 3  41902.857 13852.335 5235.691  
Tin Day 3  32908.571 31924.946 12066.496  
Control Day 7  49755.286 43532.157 16453.609  
Cobalt Day 7  70471.143 16860.181 6372.549  
Tin Day 7  42003.167 22585.685 9220.567  
 
Power of performed test with alpha = 0.050: 0.971 
 
Source of Variation DF     SS         MS    F P  
Between Treatments  8       21207898335.238    2650987291.905   4.559  <0.001  
Residual   55      31980361643.762    581461120.796    
Total    63      53188259979.000     
 
The differences in the mean values among the treatment groups are greater than would 
be expected by chance; there is a statistically significant difference (P = <0.001). 
 
All Pairwise Multiple Comparison Procedures (Tukey Test): 
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Comparisons for factor:  
Comparison    Diff of Means  p q P<0.05 
Cobalt Day 7 vs. Control Day 3 66234.571   9 7.267 Yes  
Cobalt Day 7 vs. Control Day 1 50805.143   9 5.757 Yes  
Cobalt Day 7 vs. Tin Day 3  37562.571   9 4.121 No  
Cobalt Day 7 vs. Tin Day 1  36124.000   9 3.964 No  
Cobalt Day 7 vs. Cobalt Day 3 28568.286   9 3.135 No  
Cobalt Day 7 vs. Tin Day 7  28467.976   9 3.001 No  
Cobalt Day 7 vs. Control Day 7 20715.857   9 2.273 No  
Cobalt Day 7 vs. Cobalt Day 1 17757.393   9 2.012 No  
Cobalt Day 1 vs. Control Day 3 48477.179   9 5.493 Yes  
Cobalt Day 1 vs. Control Day 1 33047.750   9 3.876 No  
Cobalt Day 1 vs. Tin Day 3  19805.179   9 2.244 No  
Cobalt Day 1 vs. Tin Day 1  18366.607   9 2.081 No  
Cobalt Day 1 vs. Cobalt Day 3 10810.893   9 1.225 No  
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Inflammation (Myeloperoxidase and MMP Levels) 
  
 The myeloperoxidase (MPO) assay was used to provide an indication of the 
amount of neutrophils located in tissue. In response to injury, neutrophils are recruited 
to the site of trauma. Neutrophils contain granules which hold myeloperoxidase.  MPO 
accounts for 5% of the total protein content of neutrophils.  This enzyme is also found 
in lesser amounts in monocytes.  MPO specifically converts hydrogen peroxide to 
hypohalous acids in order to prevent neutrophils from apoptosis. This assay was used to 
determine neutrophil levels and thus provide an indication of inflammation in each 
group of tissue: skin, interspace, and direct.  A representative standard curve using 
purified neutrophil MPO is shown in figure 13.   
MPO activity in the skin samples at all three time points was very low and 
consistent with almost all the samples. The data ranged from -12.4 milliunits/mg to 1.2 
milliunits/mg with one exception at 8.8 milliunits/mg.  From 0 to 80 milliunits of MPO 
the assay was linear with a R – squared value of 0.9841.  
In contrast to the skin, MPO activity in the interspace samples was high (figure 
14).  Statistical analysis was achieved using ANOVA (Tukey) test. See Table 5. MPO 
levels ranged from 9.6 milliunits/mg to 583.0 milliunits/mg. The R – squared value was 
0.9957. Due to some of these extremely high data, certain samples significantly over 
200 milliunits/mg were recalculated. By diluting specific tissue samples, another assay 
was performed in order to show more accurate results. The data ranged from 1.2 
 57  
milliunits/mg to 253.3 milliunits/mg with only two outliers in the negative. The R – 
squared value for the recalculated data was 0.9904.  
Lastly, the activity in the direct samples was high. The R – squared value for the 
graphed data was 0.9949. The data ranged from 9.6 milliunits/mg to 464.0 
milliunits/mg. The last four points were taken out of the data just as in the skin samples 
because when adding 0.1% hydrogen peroxide due to human error, the reaction 
occurred too quickly before being placed in the spectrometer and therefore skewed the 
data. Just as in the interspace samples, specific samples were recalculated due to 
extremely high levels of MPO and were diluted to increase the accuracy of results. The 
recalculated data ranged from -2.9 milliunits/mg to 66.1 milliunits/mg.  The R – squared 
value for the recalculated data was 0.9879.  
 
 
 
 
 
 
 
 
 
 
 
 58  
 
 
 
 
 
 
 
 
 
 
Figure 13: Representative Myeloperoxidase Standard Curve  
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Figure 14: Mean Myeloperoxidase Activities in Interspace Tissues 
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Table 5: Statistical Analysis (ANOVA) for MPO Assay Interspace Tissues 
One Way Analysis of Variance Friday, December 12, 2008, 11:09:42 
 
Data source: Data 1 in Notebook 
 
Normality Test: Failed (P = 0.012) 
 
 
Test execution ended by user request, ANOVA on Ranks begun 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks Friday, December 
12, 2008, 11:09:42 
 
Data source: Data 1 in Notebook 
 
Group   N Missing  
Control Day 1   8  0  
Tin Day1   7  0  
Cobalt Day 1   8  0  
Control Day 3   7  0  
Tin Day 3   7  0  
Cobalt Day 3   7  0  
Control Day 7   7  0  
Tin Day 7   6  0  
Cobalt Day 7   7  0  
 
Group   Median 25% 75%  
Control Day 1  2.570  1.590 3.595  
Tin Day1  1.970  1.333 2.820  
Cobalt Day 1  2.835  1.310 4.750  
Control Day 3  2.010   0.665 2.945  
Tin Day 3  3.020  2.700 3.460  
Cobalt Day 3  1.830  1.293 2.885  
Control Day 7  2.070  1.875 2.543  
Tin Day 7  3.060  2.130 3.440  
Cobalt Day 7  1.070   0.498 1.948  
 
H = 14.802 with 8 degrees of freedom.  (P = 0.063) 
 
The differences in the median values among the treatment groups are not great enough 
to exclude the possibility that the difference is due to random sampling variability; there 
is not a statistically significant difference    (P = 0.063) 
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Gelatin zymography is used to study certain enzymes in tissues and cells that 
degrade extracellular matrix. The enzymes of particular interest in this study are 
MMP’s, specifically MMP – 9.  MMP’s degrade the gelatin that was added into the gel. 
Using the Coomasie Blue dye, the clear zones in the gel are exposed showing enzymes 
capable of degrading the gelatin. When analyzing the zymograms, there are two bands 
that appear on the gels that represent the presence of MMP – 9. The top band portrays 
the latency or pro form of MMP - 9, while the bottom band portrays the active form. By 
observing the data, it was determined that by averaging the intensities of both bands 
using densitometric scoring in SigmaScan gave the most accurate results. Each intensity 
was normalized using the background on each gel corresponding with the samples. A 
standard graph was generated using a sample that had such a large amount of enzyme. 
The specific sample used with the normal 30 µg sample blew out the lane on the gel, 
which means degraded almost the whole lane. Smaller and smaller increments of this 
specific tissue sample were used to create the standard. See Figure 15. 
 The two standards showed a very consistent set of data. This gave a high 
confidence that the zymograms carried out were giving accurate results. Only a select 
few skin and direct tissue samples were analyzed, whereas all interspace samples were 
evaluated.  
 In the skin tissue samples, Day 1, 3, and 7 all showed the highest level of MMP 
– 9 in the control (untreated) samples. Day 1 showed Co PP and Sn PP treated had the 
same levels of MMP – 9. Day 3 had Co PP treated tissue trailing slightly behind the 
untreated group. The Sn PP treated group on Day 3 was also high, but had the lowest 
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levels of MMP – 9 compared to the other groups. Day 7 showed the Co PP treated 
tissue with the lowest levels and Sn PP levels high, but not has high as the untreated 
group. In the untreated skin tissue, MMP – 9 levels were fairly high and around the 
same for each day. There was not much fluctuation. The Co PP treated tissue had the 
highest levels of MMP – 9 on Day 3 and the lowest levels on Day 7. Sn PP treated 
samples had the highest levels of MMP – 9 on Day 7 and the lowest levels on Day 1.  
 Moving on to the direct tissue samples, Day 1 showed that the untreated group 
again had the highest levels of MMP – 9 and Sn PP had the smallest amount of MMP – 
9. Day 3 presented the complete opposite: Sn PP with highest MMP – 9 and untreated 
with the lowest. Day 7 demonstrated that the tin PP group had the highest level of 
enzyme and the untreated and Co PP groups had very similar levels of MMP – 9. The 
untreated samples were highest on Day 1 and lowest on Day 3. The Co PP group levels 
were highest on Day 1 and lowest on Day 7. Lastly, the Co PP group levels were 
highest on Day 7 and lowest on Day 1.  
 Interspace tissue samples showed lower levels of MMP – 9 in general compared 
with skin and direct tissues. Day 1 groups had very similar levels of enzyme with the Sn 
PP group highest and untreated animals with the lowest levels. The same trend appeared 
for Day 3 that was seen in Day 1. Day 7 portrayed different results. The Sn PP treated 
samples had the highest levels of MMP – 9 and the Co PP group had the lowest. The 
untreated group, Co PP treated group, and Sn PP treated group were all highest on Day 
3 and lowest on Day 7. See Figure 16. Statistical analysis was acheived using the 
program, SigmaStat. An ANOVA (Tukeys) test was performed. See Table 6. 
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Figure 15: Linear Relationship Between Matrix Metalloproteinase-9 Levels and 
Densitometry.  Serial 2-fold dilutions of a single sample were subjected to gelatin 
zymography. This is a log vs. log plot. Results indicate that the zones of clearing have 
linear dependency with MMP-9 concentration.  
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Figure 16: Gelatin Zymography of Interspace Tissues 
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Table 6: Statistical Analysis (ANOVA) for Gelatin Zymography Interspace Tissues 
 
 
One Way Analysis of Variance Thursday, December 11, 2008, 18:02:10 
 
Data source: Data 1 in Notebook 
 
Normality Test: Failed (P = 0.024) 
 
Test execution ended by user request, ANOVA on Ranks begun 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks Thursday, December 
11, 2008, 18:02:10 
 
Data source: Data 1 in Notebook 
 
Group   N Missing  
Control Day 1   8  0  
Cobalt Day 1   8  0  
Tin Day 1   7  0  
Control Day 3   7  0  
Cobalt Day 3   7  0  
Tin Day 3   7  0  
Control Day 7   7  0  
Cobalt Day 7   7  0  
Tin Day 7   6  0  
 
Group   Median  25%  75%  
Control Day 1  181798.500 122575.000 257089.000  
Cobalt Day 1  201503.500 132543.500 284487.500  
Tin Day 1  232309.000 137981.000 301698.000  
Control Day 3  181456.000 137962.500 268782.750  
Cobalt Day 3  160583.000 92673.250 216154.750  
Tin Day 3  236226.000 180620.000 249004.000  
Control Day 7  276065.000 157940.250 328486.000  
Cobalt Day 7  185773.000 161727.750 268342.500  
Tin Day 7  372996.500 181368.000 584495.000  
 
H = 8.673 with 8 degrees of freedom.  (P = 0.371) 
 
The differences in the median values among the treatment groups are not great enough 
to exclude the possibility that the difference is due to random sampling variability; there 
is not a statistically significant difference    (P = 0.371) 
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Collagenase Assay 
 
 Collagenase is an enzyme that cleaves collagen into two fragments. At certain 
temperatures, the two fragments formed will denature. The radioactive collagen type I 
used will fluoresce to detect activity.  
 The tissue samples used in these assays did not show any cleavage of collagen. 
The wound fluid was used in every assay as a common standard. This wound fluid 
would show the two fragments of collagen on each assay, and the hope was to see these 
fragments in certain tissues. The reason these fragments did not show up is unknown. 
The tissues may have been sitting for too long since this was the last test performed, but 
it is hard to tell. Neither treatment options nor days of harvest made a difference in the 
tissue samples pertaining to the collagenase assay. By observing figures 17-19, the only 
fragments observed on the all assays were the wound fluid samples.  
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Lane          10           9         8         7          6         5          4           3          2         1              
 
 
Lane 1: Marker  
Lane 2: Wound Fluid Negative 
Lane 3: Wound Fluid Active 
Lane 4: Wound Fluid Total 
Lane 5: 0910 Interspace Control Day 1 Active 
Lane 6: 0910 Interspace Control Day 1 Total 
Lane 7: 0502 Interspace Cobalt PP Day 1 Active 
Lane 8: 0502 Interspace Cobalt PP Day 1 Total 
Lane 9: 0803 Interspace Tin PP Day 1 Active 
Lane 10: 0803 Interspace Tin PP Day 1 Total 
 
 
 
 
 
Figure 17 : Collagenase Activity Assay 1
72 kDa 
66 kDa 
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Lane          10            9          8           7           6          5          4          3            2       1 
 
 
Lane 1: Marker  
Lane 2: Wound Fluid Negative 
Lane 3: Wound Fluid Active 
Lane 4: Wound Fluid Total 
Lane 5: 0306 Interspace Control Day 3 Active 
Lane 6: 0306 Interspace Control Day 3 Total 
Lane 7: 0406 Interspace Cobalt PP Day 3 Active 
Lane 8: 0406 Interspace Cobalt PP Day 3 Total 
Lane 9: 0903 Interspace Tin PP Day 3 Active 
Lane 10: 0903 Interspace Tin PP Day 3 Total 
 
 
 
 
 
Figure 18: Collagenase Activity Assay 2 
72 kDa 
66 kDa 
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Lane        10         9          8          7          6         5          4           3         2         1              
 
 
Lane 1: Marker  
Lane 2: Wound Fluid Negative 
Lane 3: Wound Fluid Active 
Lane 4: Wound Fluid Total 
Lane 5: 0609 Interspace Control Day 7 Active 
Lane 6: 0609 Interspace Control Day 7 Total 
Lane 7: 0408 Interspace Cobalt PP Day 7 Active 
Lane 8: 0408 Interspace Cobalt PP Day 7 Total 
Lane 9: 0901 Interspace Tin PP Day 7 Active 
Lane 10: 0901 Interspace Tin PP Day 7 Total 
 
 
 
 
 
Figure 19: Collagenase Activity Assay 3
72 kDa 
66 kDa 
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Discussion 
 
 Burn wound conversion is an ongoing struggle for physicians and their burn 
patients. Research is being conducted in order to try and understand the mechanics of 
burn conversion and methods that can help to prevent it. This study examined the ability 
of two heavy metal protoporphyrins to modulate burn wound conversion in an animal 
model. Heavy metal protoporphyrins are modulators of the expression or activity of 
HO-1. Both Co PP and Sn PP induced the expression of HO-1 at the protein level.  Sn 
PP is also an effective inhibitor of HO-1 activity.   Animals receiving a single bolus of 
Co PP 24 hrs prior to burn injury exhibited significantly less necrosis than either of the 
other two groups. 
In general, levels of inflammation within the interspace region as reflected by 
MPO activity and MMP-9 zymography correlated with levels of necrosis.   Attempts at 
assessing collagenolytic activity were not successful.  Neutrophil collagenase (MMP-8) 
is abundant in human neutrophils and wound fluid obtained from a human chronic 
wound contained easily detectable levels collagenolytic activity.   
 This research model was conducted using rats. The downside to this is that 
factors tested in rats cannot be directly compared to humans. For example, when the 
collagenase assay was performed, MMP-8 was abundant in human wound fluid, but not 
in the animal tissue. A possibility could be that MMP-8 is just not involved in 
inflammation in rats as it is in humans. The data collected appeared to correlate with 
research pertaining to humans, but it can not be certain. Until more research is 
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conducted in human burn tissue, it is hard to determine whether this model can be 
translated to humans.  
An additional issue is whether heavy metal protoporphyrins can still 
significantly modulate conversion when administered post-wounding. One of the 
disadvantages to burn research is that it is impossible to know when an individual will 
be burned. An interesting experiment would be to determine if heavy metal 
protoporphyrins have any effect when administered to rats after the injury has occurred. 
This could allow for a more practical method reducing burn wound conversion.   
Although heavy metal protopophyrins modulate HO-1 expression and activity, 
the approach used in this study does not definitively address whether HO-1 expression 
itself, has a role in modulation of conversion.  Future studies directly testing the ability 
of HO-1 to modulate burn wound conversion still need to be performed.  If HO-1 is 
indeed serving a function, it will be necessary to determine the mechanism involved.  It 
has not been determined where exactly HO-1 acting. Is HO-1 mainly removing heme, 
which can act as a potent oxidant?  The key purpose of HO-1 may be to induce carbon 
monoxide (CO) and biliverdin/bilirubin, which act as anti-oxidants and anti-apoptotic 
molecules. Focusing on the true manner in which HO-1 expression occurs could give 
extremely effective results. Lastly, it would be beneficial to determine how CO and 
biliverdin/bilirubin directly or indirectly influence the injury. Their specific targets of 
action would help to ascertain methods involved in decreasing the inflammatory 
response in burn wounds in order to prevent conversion. 
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